AVDL logo

Avadel Pharmaceuticals (AVDL) Total Debt

Annual Total Debt

$2.62 M
-$128.40 M-98.00%

December 31, 2023


Summary


Performance

AVDL Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVDLbalance sheetmetrics:

Quarterly Total Debt

$1.94 M
-$233.00 K-10.72%

September 30, 2024


Summary


Performance

AVDL Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVDLbalance sheetmetrics:

Total Debt Formula

Total Debt = Short Term Debt + Long Term Debt

AVDL Total Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-98.0%-26.0%
3 y3 years-98.0%-91.2%
5 y5 years-97.7%-91.2%

AVDL Total Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-98.2%at low-98.7%at low
5 y5-year-98.2%at low-98.7%at low
alltimeall time-98.2%+882.8%-98.7%-100.0%

Avadel Pharmaceuticals Total Debt History

DateAnnualQuarterly
Sep 2024
-
$1.94 M(-10.7%)
Jun 2024
-
$2.17 M(-9.5%)
Mar 2024
-
$2.40 M(-8.5%)
Dec 2023
$2.62 M(-98.0%)
$2.62 M(-89.1%)
Sep 2023
-
$24.03 M(+8.6%)
Jun 2023
-
$22.12 M(-80.8%)
Mar 2023
-
$115.16 M(-12.1%)
Dec 2022
$131.02 M(-9.6%)
$131.02 M(-5.2%)
Sep 2022
-
$138.27 M(+1.3%)
Jun 2022
-
$136.51 M(-5.9%)
Mar 2022
-
$145.13 M(+0.1%)
Dec 2021
$145.00 M(+11.1%)
$145.00 M(+0.7%)
Sep 2021
-
$144.05 M(+0.1%)
Jun 2021
-
$143.86 M(+0.1%)
Mar 2021
-
$143.66 M(+10.1%)
Dec 2020
$130.52 M(+4.7%)
$130.52 M(+1.2%)
Sep 2020
-
$129.01 M(+1.2%)
Jun 2020
-
$127.53 M(+1.2%)
Mar 2020
-
$126.07 M(+1.1%)
Dec 2019
$124.65 M(+7.6%)
$124.65 M(+0.0%)
Sep 2019
-
$124.63 M(+1.0%)
Jun 2019
-
$123.35 M(+1.0%)
Mar 2019
-
$122.15 M(+5.4%)
Dec 2018
$115.84 M(>+9900.0%)
$115.84 M(+1.2%)
Sep 2018
-
$114.49 M(+1.2%)
Jun 2018
-
$113.15 M(+1.2%)
Mar 2018
-
$111.84 M(>+9900.0%)
Dec 2017
$267.00 K(-67.2%)
$267.00 K(-70.8%)
Sep 2017
-
$915.00 K(+3.4%)
Jun 2017
-
$885.00 K(+7.0%)
Mar 2017
-
$827.00 K(+1.5%)
Dec 2016
$815.00 K(-27.1%)
$815.00 K(-20.1%)
Sep 2016
-
$1.02 M(-4.8%)
Jun 2016
-
$1.07 M(-8.0%)
Mar 2016
-
$1.16 M(+4.1%)
Dec 2015
$1.12 M(-69.9%)
$1.12 M(>+9900.0%)
Sep 2015
-
$0.00(-100.0%)
Jun 2015
-
$149.69 M(+21.5%)
Mar 2015
-
$123.19 M(+3214.1%)
Dec 2014
$3.72 M(-95.7%)
$3.72 M(-96.1%)
Sep 2014
-
$95.95 M(+9.5%)
Jun 2014
-
$87.59 M(+17.1%)
Mar 2014
-
$74.82 M(-12.5%)
Dec 2013
$85.55 M(+131.9%)
$85.55 M(-0.5%)
Sep 2013
-
$85.97 M(+1.2%)
Jun 2013
-
$84.99 M(+56.6%)
Mar 2013
-
$54.26 M(+47.1%)
Dec 2012
$36.88 M(+807.8%)
$36.88 M(>+9900.0%)
Sep 2012
-
$0.00(-100.0%)
Jun 2012
-
$50.10 M(-0.2%)
Mar 2012
-
$50.18 M(+1135.1%)
Dec 2011
$4.06 M(+0.2%)
$4.06 M(-3.1%)
Sep 2011
-
$4.20 M(+0.9%)
Jun 2011
-
$4.16 M(-6.7%)
Mar 2011
-
$4.46 M(+9.8%)
Dec 2010
$4.06 M
$4.06 M(+1.0%)
Sep 2010
-
$4.02 M(+11.0%)
DateAnnualQuarterly
Jun 2010
-
$3.62 M(-0.7%)
Mar 2010
-
$3.65 M(-6.6%)
Dec 2009
$3.90 M(+25.2%)
$3.90 M(+21.5%)
Sep 2009
-
$3.21 M(+3.4%)
Jun 2009
-
$3.11 M(+6.0%)
Mar 2009
-
$2.93 M(-5.9%)
Dec 2008
$3.12 M(-8.9%)
$3.12 M(-3.8%)
Sep 2008
-
$3.24 M(-10.5%)
Jun 2008
-
$3.62 M(+1.5%)
Mar 2008
-
$3.57 M(+4.2%)
Dec 2007
$3.42 M(-1.8%)
$3.42 M(+0.3%)
Sep 2007
-
$3.42 M(+1.7%)
Jun 2007
-
$3.36 M(-1.6%)
Mar 2007
-
$3.41 M(-2.1%)
Dec 2006
$3.49 M(-8.0%)
$3.49 M(+1.1%)
Sep 2006
-
$3.45 M(-3.1%)
Jun 2006
-
$3.56 M(-1.0%)
Mar 2006
-
$3.60 M(-5.1%)
Dec 2005
$3.79 M(+29.4%)
$3.79 M(-15.1%)
Sep 2005
-
$4.46 M(+58.7%)
Jun 2005
-
$2.81 M(-9.8%)
Mar 2005
-
$3.12 M(+6.4%)
Dec 2004
$2.93 M(+33.6%)
$2.93 M(+31.7%)
Sep 2004
-
$2.22 M(0.0%)
Jun 2004
-
$2.22 M(+6.3%)
Mar 2004
-
$2.09 M(-4.6%)
Dec 2003
$2.19 M(-10.9%)
$2.19 M(+20.0%)
Sep 2003
-
$1.83 M(-3.1%)
Jun 2003
-
$1.89 M(+1.9%)
Mar 2003
-
$1.85 M(-24.8%)
Dec 2002
$2.46 M(+45.2%)
$2.46 M(+20.1%)
Sep 2002
-
$2.05 M(>+9900.0%)
Jun 2002
-
$0.00(0.0%)
Mar 2002
-
$0.00(-100.0%)
Dec 2001
$1.70 M(-23.6%)
$1.70 M(>+9900.0%)
Sep 2001
-
$0.00(0.0%)
Jun 2001
-
$0.00(0.0%)
Mar 2001
-
$0.00(-100.0%)
Dec 2000
$2.22 M(-15.8%)
$2.22 M(>+9900.0%)
Sep 2000
-
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
Mar 2000
-
$0.00(-100.0%)
Dec 1999
$2.64 M(-20.5%)
$2.64 M(>+9900.0%)
Sep 1999
-
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
Mar 1999
-
$0.00(-100.0%)
Dec 1998
$3.32 M(-2.4%)
$3.32 M(>+9900.0%)
Sep 1998
-
$0.00(0.0%)
Jun 1998
-
$0.00(-100.0%)
Mar 1998
-
$3.30 M(-2.9%)
Dec 1997
$3.40 M(+61.9%)
$3.40 M(>+9900.0%)
Sep 1997
-
$0.00(0.0%)
Jun 1997
-
$0.00(0.0%)
Mar 1997
-
$0.00(-100.0%)
Dec 1996
$2.10 M
$2.10 M(>+9900.0%)
Sep 1996
-
$0.00(0.0%)
Jun 1996
-
$0.00(-100.0%)
Mar 1996
-
$2.00 M

FAQ

  • What is Avadel Pharmaceuticals annual total debt?
  • What is the all time high annual total debt for Avadel Pharmaceuticals?
  • What is Avadel Pharmaceuticals annual total debt year-on-year change?
  • What is Avadel Pharmaceuticals quarterly total debt?
  • What is the all time high quarterly total debt for Avadel Pharmaceuticals?
  • What is Avadel Pharmaceuticals quarterly total debt year-on-year change?

What is Avadel Pharmaceuticals annual total debt?

The current annual total debt of AVDL is $2.62 M

What is the all time high annual total debt for Avadel Pharmaceuticals?

Avadel Pharmaceuticals all-time high annual total debt is $145.00 M

What is Avadel Pharmaceuticals annual total debt year-on-year change?

Over the past year, AVDL annual total debt has changed by -$128.40 M (-98.00%)

What is Avadel Pharmaceuticals quarterly total debt?

The current quarterly total debt of AVDL is $1.94 M

What is the all time high quarterly total debt for Avadel Pharmaceuticals?

Avadel Pharmaceuticals all-time high quarterly total debt is $149.69 M

What is Avadel Pharmaceuticals quarterly total debt year-on-year change?

Over the past year, AVDL quarterly total debt has changed by -$683.00 K (-26.03%)